drugset / Trial / NCT00118417
Therapies for Treatment-Resistant Panic Disorder Symptoms
Phase 2/3
Completed
46 enrolled
Massachusetts General Hospital
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will determine the effectiveness of different treatments for panic disorder symptoms in individuals who still have symptoms after initial treatment with medication.
Timeline
- Start
- 1999-03
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clonazepam | Small molecule | — | — |
| Subject | Sertraline | Small molecule | 100 mg | — |
| Subject | Sertraline | Small molecule | 200 mg | — |